These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 24300023)

  • 1. An unusual presentation of heparin-induced thrombocytopenia in the setting of catheter-directed ablation of atrial fibrillation.
    Vaidya R; Pruthi R; Thompson C
    Blood Coagul Fibrinolysis; 2014 Mar; 25(2):188-90. PubMed ID: 24300023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring and management of heparin-induced thrombocytopenia.
    Rogers B; Little Nj; Jones C
    Br J Hosp Med (Lond); 2009 Nov; 70(11):630-3. PubMed ID: 20081589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.
    Demma LJ; Winkler AM; Levy JH
    Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-induced thrombocytopenia: clinical manifestations and management strategies.
    Menajovsky LB
    Am J Med; 2005 Aug; 118 Suppl 8A():21S-30S. PubMed ID: 16125511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timely diagnosis and management of heparin-induced thrombocytopenia in a frequent request, low incidence single centre using clinical 4T's score and particle gel immunoassay.
    Bryant A; Low J; Austin S; Joseph JE
    Br J Haematol; 2008 Dec; 143(5):721-6. PubMed ID: 19036016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparins, low-molecular-weight heparins, and pentasaccharides.
    Dinwoodey DL; Ansell JE
    Clin Geriatr Med; 2006 Feb; 22(1):1-15, vii. PubMed ID: 16377464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-induced thrombocytopenia in patients with Philadelphia-negative myeloproliferative disorders and unusual splanchnic or cerebral vein thrombosis.
    Randi ML; Tezza F; Scapin M; Duner E; Scarparo P; Scandellari R; Fabris F
    Acta Haematol; 2010; 123(3):140-5. PubMed ID: 20134155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Egyptian experience of reliability of 4T's score in diagnosis of heparin induced thrombocytopenia syndrome.
    Tawfik NM; Hegazy MA; Hassan EA; Ramadan YK; Nasr AS
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):701-5. PubMed ID: 22008905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fondaparinux for the treatment of acute heparin-induced thrombocytopenia: a single-center experience.
    Grouzi E; Kyriakou E; Panagou I; Spiliotopoulou I
    Clin Appl Thromb Hemost; 2010 Dec; 16(6):663-7. PubMed ID: 19825921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 4Ts scoring system for heparin-induced thrombocytopenia in medical-surgical intensive care unit patients.
    Crowther MA; Cook DJ; Albert M; Williamson D; Meade M; Granton J; Skrobik Y; Langevin S; Mehta S; Hebert P; Guyatt GH; Geerts W; Rabbat C; Douketis J; Zytaruk N; Sheppard J; Greinacher A; Warkentin TE;
    J Crit Care; 2010 Jun; 25(2):287-93. PubMed ID: 20149589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fondaparinux-associated heparin-induced thrombocytopenia.
    Bhatt VR; Aryal MR; Shrestha R; Armitage JO
    Eur J Haematol; 2013 Nov; 91(5):437-41. PubMed ID: 23905719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical presentation and laboratory diagnosis of heparin-induced thrombocytopenia.
    Pollak ES; Abrams CS
    Semin Thorac Cardiovasc Surg; 2005; 17(1):80-4. PubMed ID: 16104365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-induced thrombocytopenia: a complication of thromboprophylaxis.
    Kejariwal D
    J Bone Joint Surg Br; 2006 Mar; 88(3):392-3. PubMed ID: 16498019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer patients requiring interruption of long-term warfarin because of surgery or chemotherapy induced thrombocytopenia: the use of fixed sub-therapeutic doses of low-molecular weight heparin.
    Saccullo G; Malato A; Raso S; Santoro M; Zammit V; Casuccio A; Siragusa S
    Am J Hematol; 2012 Apr; 87(4):388-91. PubMed ID: 22374861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a pretest scoring system (4Ts) for the diagnosis of heparin-induced thrombocytopenia in a university hospital setting.
    Vatanparast R; Lantz S; Ward K; Crilley PA; Styler M
    Postgrad Med; 2012 Nov; 124(6):36-42. PubMed ID: 23322137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of consecutive repeat HIT ELISA testing for heparin-induced thrombocytopenia.
    Chan M; Malynn E; Shaz B; Uhl L
    Am J Hematol; 2008 Mar; 83(3):212-7. PubMed ID: 17910041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unfractionated heparin versus low-molecular-weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients.
    Ang E
    Clin Nurse Spec; 2013; 27(5):229-30. PubMed ID: 23942101
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cerebrovascular complications of immunologically mediated heparin-induced thrombocytopenia].
    Macha K; Kloska S; Dörfler A; Raaz-Schrauder D; Schwab S; Köhrmann M; Seifert F
    Fortschr Neurol Psychiatr; 2014 Mar; 82(3):149-54. PubMed ID: 24615586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin induced thrombocytopenia and thrombosis in a tertiary care hospital.
    Ban-Hoefen M; Francis C
    Thromb Res; 2009 Jun; 124(2):189-92. PubMed ID: 19195684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-induced thrombocytopenia with acute aortic and renal thrombosis in a patient treated with low-molecular-weight heparin.
    Chevalier J; Ducasse E; Dasnoy D; Puppinck P
    Eur J Vasc Endovasc Surg; 2005 Feb; 29(2):209-12. PubMed ID: 15649731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.